(ACOG) (2015) recommended that all patients receive information on the risks and benefits of various methods of prenatal screening and diagnostic testing for fetal aneuploidies, including the option of no testing. Studies published to date on noninvasive prenatal screening for fetal aneuploidies have reported rare but occasional false-positives..